Amyloid β binding proteins in vitro and in normal human cerebrospinal fluid
- 1 May 1995
- journal article
- Published by Elsevier in Neuroscience Letters
- Vol. 191 (1-2), 79-82
- https://doi.org/10.1016/0304-3940(95)11565-7
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Is Alzheimer's disease an apolipoprotein E amyloidosis?The Lancet, 1995
- Soluble amyloid β-protein in the cerebrospinal fluid from patients with Alzheimer's disease, vascular dementia and controlsJournal of the Neurological Sciences, 1994
- Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filamentsNature, 1994
- Dorothy Russell Memorial Lecture The molecular pathology of Alzheimer's disease: are we any closer to understanding the neurodegenerative process?Neuropathology and Applied Neurobiology, 1994
- Identification of Proteins Associated with Apolipoprotein A-I-Containing Lipoproteins Purified by Selected-Affinity ImmunosorptionBiochemistry, 1994
- Cerebrospinal fluid inhibits Alzheimer β‐amyloid fibril formation in vitroAnnals of Neurology, 1993
- The cerebrospinal-fluid soluble form of Alzheimer's amyloid β is complexed to SP-40,40 (apolipoprotein J), an inhibitor of the complement membrane-attack complexBiochemical Journal, 1993
- Apolipoprotein E: Binding to Soluble Alzheimer′s β-AmyloidBiochemical and Biophysical Research Communications, 1993
- SP-40,40 is a constituent of Alzheimer's amyloidActa Neuropathologica, 1992
- Apolipoprotein E: A pathological chaperone protein in patients with cerebral and systemic amyloidNeuroscience Letters, 1992